Cell Source Current Ratio Growth & History (CLCS)

Cell Source's current ratio was 0.02 for fiscal 2024.

View full Cell Source company overview

Cell Source annual current ratio history

Cell Source annual current ratio

Fiscal yearPeriod endedCurrent ratioChangeGrowth
20242024-12-310.020.00+23.26%
20232023-12-310.01−0.02−60.70%
20222022-12-310.030.00+1.54%
20212021-12-310.03−0.02−42.09%
20202020-12-310.05
20172017-12-310.100.07+220.03%
20162016-12-310.03−0.00−9.43%
20152015-12-310.040.01+16.40%
20142014-12-310.03−0.09−73.49%
20132013-12-310.12

Cell Source current ratio trends

Between the periods ended 2013-12-31 and 2024-12-31, Cell Source's current ratio decreased from 0.12 to 0.02, a change of −0.10. The latest reported quarter, Q4 2024, shows 0.02.

About the metric

What the current ratio means

The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.

Calculation and source

How the current ratio is calculated

TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Cell Source source filings ↗

Community posts

It’s quiet here.

No posts about CLCS yet. Start the conversation.

Write the first post